6 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
Follow gevokizumab: new trials by email Literature Review of gevokizumab trials Research Report on gevokizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum gevokizumab, Placebo, gevokizumab open-label - Pyoderma Gangrenosum | Phase 3 | Terminated | XOMA (US) LLC | 9 | 2014-12-01 | 2016-04-27 |
| Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis Placebo, Gevokizumab - Behcet's Disease Uveitis | Phase 3 | Terminated | XOMA (US) LLC | 4 | 2014-11-01 | 2015-12-29 |
| An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum gevokizumab, Placebo, gevokizumab open-label - Pyoderma Gangrenosum | Phase 3 | Terminated | XOMA (US) LLC | 16 | 2014-11-01 | 2016-04-27 |
| A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum gevokizumab - Pyoderma Gangrenosum | Phase 3 | Terminated | XOMA (US) LLC | 15 | 2014-11-01 | 2016-04-27 |
| Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) Gevokizumab - Chronic Uveitis | Phase 3 | Terminated | Institut de Recherches Internationales Servier | 71 | 2014-08-01 | 2020-01-03 |
| Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B) Gevokizumab, Placebo - Behcet's Uveitis | Phase 3 | Terminated | Institut de Recherches Internationales Servier | 84 | 2012-11-01 | 2020-01-03 |
Pyoderma Gangrenosum (3) · Uveitis (2) · Behcet Syndrome (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1)
XOMA (US) LLC (4) · Institut de Recherches Internationales Servier (2)
United States (4) · Australia (3) · Canada (2) · South Korea (2) · United Kingdom (2) · Austria (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Portugal (1) · Spain (1) · Taiwan (1) · Tunisia (1) · Turkey (Türkiye) (1)